RENAL SAFETY OF LONG TERM NSAID USE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

被引:0
作者
Kim, Y. E. [1 ]
Park, S. Y. [2 ]
Ahn, S. M. [1 ]
Hong, S. [1 ]
Lee, C. K. [1 ]
Yoo, B. [1 ]
Oh, J. S. [3 ]
Kim, Y. G. [1 ]
机构
[1] Univ Ulsan, Coll Med, Dept Rheumatol, Asan Med Ctr, Seoul, South Korea
[2] Korea Natl Open Univ, Dept Stat & Data Sci, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Dept Med Informat, Big Data Res Ctr,Asan Med Ctr, Seoul, South Korea
关键词
Spondyloarthritis; DECLINE;
D O I
10.1136/annrheumdis-2023-eular.2916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0674
引用
收藏
页码:618 / 619
页数:2
相关论文
共 50 条
  • [21] The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
    Swart, I. A. P.
    Visman, I. M.
    Heslinga, M.
    van der Horst-Bruinsma, I. E.
    van Denderen, J. C.
    Nurmohamed, M. T.
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (12) : 3747 - 3752
  • [22] The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
    I. A. P. Swart
    I. M. Visman
    M. Heslinga
    I. E. van der Horst-Bruinsma
    J. C. van Denderen
    M. T. Nurmohamed
    [J]. Clinical Rheumatology, 2022, 41 : 3747 - 3752
  • [23] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    A. Deodhar
    P. J. Mease
    I. B. McInnes
    X. Baraliakos
    K. Reich
    A. Blauvelt
    C. Leonardi
    B. Porter
    A. Das Gupta
    A. Widmer
    L. Pricop
    T. Fox
    [J]. Arthritis Research & Therapy, 21
  • [24] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    Deodhar, A.
    Mease, P. J.
    McInnes, I. B.
    Baraliakos, X.
    Reich, K.
    Blauvelt, A.
    Leonardi, C.
    Porter, B.
    Gupta, A. Das
    Widmer, A.
    Pricop, L.
    Fox, T.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [25] Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
    Moskal, Mateusz
    Krawiec, Piotr
    Zareba, Wojciech
    Swierczek, Izabella
    Ratusznik, Jakub
    Raputa, Wiktor
    Zielinski, Maciej
    Batko, Krzysztof
    Huk, Mikita
    Batko, Bogdan
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [26] Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1793 - 1799
  • [27] EFFICACY AND SAFETY OF UPADACITINIB IN ANKYLOSING SPONDYLITIS. REAL WORLD DATA
    Merino Argumanez, C.
    Secada-Gomez, C.
    Vergara, C.
    Urruticoechea-Arana, A.
    Alonso Castro, S.
    Garcia-Vivar, M. L.
    Moreno, M.
    Almodovar Gonzalez, R.
    Blanco, R.
    Sanz, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1693 - 1694
  • [28] Gait characteristics in patients with ankylosing spondylitis: a systematic review
    Soulard, J.
    Vaillant, J.
    Agier, C-T
    Vuillerme, N.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 173 - 186
  • [29] SPONDYLOARTHRITIS IN FIRST DEGREE RELATIVES OF ANKYLOSING SPONDYLITIS PATIENTS
    Bubova, K.
    Hasikova, L.
    Gregova, M.
    Mintalova, K.
    Forejtova, S.
    Senolt, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1749 - 1749
  • [30] Altered kynurenine pathway metabolism in patients with ankylosing spondylitis
    Onmaz, Duygu Eryavuz
    Sivrikaya, Abdullah
    Isik, Kevser
    Abusoglu, Sedat
    Gezer, Ilknur Albayrak
    Yerlikaya, Fatma Humeyra
    Abusoglu, Gulsum
    Unlu, Ali
    Tezcan, Dilek
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99